CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-21 | O'Malley Brendan M. SVP, General Counsel | Shares withheld for taxes | −479 | $3.72 | $2K | 9,071 |
| 2022-07-21 | Vazzano Joseph Walter Chief Financial Officer | Grant or award | +12,000 | 20,000 | ||
| 2022-06-15 | Alvino Mark Director | Sale | −20,000 | $0.15 | $3K | 27,181 |
| 2022-06-06 | Alvino Mark Director | Sale | −35,000 | $0.16 | $5K | 47,181 |
| 2022-06-01 | Seshadri Vishwas Chief Executive Officer | Shares withheld for taxes | −81,525 | $0.16 | $13K | 268,475 |
| 2022-03-14 | Vazzano Joseph Walter Chief Financial Officer | Grant or award | +200,000 | 200,000 | ||
| 2021-12-06 | O'Malley Brendan M. SVP, General Counsel | Sale | −8,880 | $0.57 | $5K | 204,750 |
| 2021-11-05 | O'Malley Brendan M. SVP, General Counsel | Sale | −8,880 | $0.89 | $8K | 213,630 |
| 2021-10-15 | Seshadri Vishwas Chief Executive Officer | Grant or award | +50,000 | 350,000 | ||
| 2021-10-15 | Seshadri Vishwas Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2021-10-11 | O'Malley Brendan M. SVP, General Counsel | Sale | −25,734 | $0.90 | $23K | 222,510 |
| 2021-10-08 | O'Malley Brendan M. SVP, General Counsel | Sale | −22,763 | $1.05 | $24K | 248,244 |
| 2021-10-08 | CARR EDWARD Chief Financial Officer | Sale | −29,122 | $1.05 | $31K | 400,169 |
| 2021-10-07 | Wider Todd Director | Sale | −25,000 | $0.97 | $24K | 0 |
| 2021-10-05 | O'Malley Brendan M. SVP, General Counsel | Sale | −2,447 | $1.05 | $3K | 271,007 |
| 2021-09-30 | Amoroso Michael Chief Executive Officer | Sale | −45,409 | $1.09 | $49K | 604,637 |
| 2021-09-20 | O'Malley Brendan M. SVP, General Counsel | Grant or award | +136,000 | 273,454 | ||
| 2021-09-20 | O'Malley Brendan M. SVP, General Counsel | Grant or award · Stock Option (right to buy) | +272,000 | 272,000 | ||
| 2021-08-10 | CARR EDWARD Chief Financial Officer | Grant or award | +238,000 | 429,291 | ||
| 2021-08-10 | CARR EDWARD Chief Financial Officer | Grant or award · Stock Option (right to buy) | +476,000 | 476,000 |
Page 10 of 12 · 223 trades